# Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

> **NCT02074189** · PHASE3 · UNKNOWN · sponsor: **Southwest Hospital, China** · enrollment: 200 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Gemcitabine, Cisplatin

## Key facts

- **NCT ID:** NCT02074189
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074189, "Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02074189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*